HALOZYME THERAPEUTICS, INC. Annual Interest Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2011 to 2023.
  • Halozyme Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $4.51M, a 0.79% decline year-over-year.
  • Halozyme Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $18.7M, a 5.09% decline year-over-year.
  • Halozyme Therapeutics, Inc. annual Interest Expense for 2023 was $18.8M, a 10.7% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Interest Expense for 2022 was $16.9M, a 125% increase from 2021.
  • Halozyme Therapeutics, Inc. annual Interest Expense for 2021 was $7.53M, a 63.1% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $18.8M +$1.82M +10.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $16.9M +$9.42M +125% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $7.53M -$12.9M -63.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $20.4M +$8.75M +75.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $11.6M -$6.41M -35.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $18M -$3.94M -17.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $22M +$2.01M +10% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $20M +$14.8M +284% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-21
2015 $5.2M -$380K -6.81% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
2014 $5.58M +$2.31M +70.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $3.27M +$3.27M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $0 $0 Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $0 Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.